Rivoglitazone

From Self-sufficiency

Revision as of 04:27, 1 August 2010 by Fvasconcellos (Talk) (hacked indeed)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Rivoglitazone
Systematic (IUPAC) name
File:Rivoglitazone.svg
(RS)-5-{4-[(6-methoxy-1-methyl-1H-benzimidazol-2-yl) methoxy]benzyl}-1,3-thiazolidine-2,4-dione
Identifiers
CAS Number	185428-18-6
ATC code	none
PubChem	CID 3055168
Chemical data
Formula	C₂₀H₁₉N₃O₄S
Molar mass	397.448 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Rivoglitazone (INN) is a thiazolidinedione undergoing research for use in the treatment of type 2 diabetes.^[1]

It is being developed by Daiichi Sankyo Co.

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

Biguanides	Metformin^# · Buformin^‡ · Phenformin^‡
TZDs (PPAR)	Pioglitazone · Rivoglitazone^† · Rosiglitazone · Troglitazone^‡
Dual PPAR agonists	Aleglitazar^† · Muraglitazar^§ · Tesaglitazar^§

Sulfonylureas	1st generation: Acetohexamide · Carbutamide · Chlorpropamide · Gliclazide · Tolbutamide · Tolazamide 2nd generation: Glibenclamide (Glyburide)^# · Glipizide · Gliquidone · Glyclopyramide 3rd generation: Glimepiride
Meglitinides/"glinides"	Nateglinide · Repaglinide · Mitiglinide

Analogs/other insulins

Other

Alpha-glucosidase inhibitors	Acarbose · Miglitol · Voglibose
Amylin analog	Pramlintide
SGLT2 inhibitors	Canagliflozin^† · Dapagliflozin^† · Remogliflozin^† · Sergliflozin^†
Other	Benfluorex · Tolrestat^‡

45px	This drug article relating to the gastrointestinal system is a stub. You can help ssf by expanding it. v d e

↑ Schimke K, Davis TM (2007). "Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes". Curr Opin Investig Drugs. 8 (4): 338–44. PMID 17458185.